SPOTLIGHT -
May 7th 2024
Here are highlights from the third day of this year’s APA Annual Meeting.
May 6th 2024
New research on tardive dyskinesia has also been featured at the 2024 APA Annual Meeting.
This 2024 APA Annual Meeting poster estimated the prevalence of tardive dyskinesia in antipsychotic users in the US, and found rates ranging from 94.1-127.4 per 1000 antipsychotic users.
May 15th 2023
Deutetrabenazine extended-release tablets are now available.
February 23rd 2023
A new, easy-to-use scale might be able to help clinicians determine the impact of tardive dyskinesia on patient functioning.